Eyal Zimlichman

Eyal Zimlichman

Auto-generated profile, based on publicly available information

Eyal Zimlichman

Sheba Medical Centre, Tel Hashomer, Israel

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
JDJacques D. Donzé
Jacques D. Donzé
MWMark V Williams
Mark V Williams
EREdmondo J. Robinson
Edmondo J. Robinson
EZEyal Zimlichman
Eyal Zimlichman
DADrahomir Aujesky
Drahomir Aujesky
JSJeffrey L. Schnipper
Jeffrey L. Schnipper
Hospital readmissions are frequent, harmful and costly—18% of Medicare patients can expect to be readmitted within 30 days in the United States at a cost of more than $17 billion.1 Recent changes in health care policy aimed at reducing readmission have substantially increased attention to this major health care issue.

25 April 2024 in NEJM AI
Verified
Journal Article
Closed access
ASAli Soroush
Ali Soroush
BGBenjamin S Glicksberg
Benjamin S Glicksberg
EZEyal Zimlichman
Eyal Zimlichman
YBYiftach Barash
Yiftach Barash
RFRobert Freeman
Robert Freeman
EKEyal Klang
Eyal Klang

1 August 2014 in Critical Care Medicine
Verified
Journal Article
Open access
SSSarah P. Slight
Sarah P. Slight
CFCalvin Franz
Calvin Franz
MOMichael Olugbile
Michael Olugbile
HBHarvey V. Brown
Harvey V. Brown
DBDavid W. Bates
David W. Bates
EZEyal Zimlichman
Eyal Zimlichman
To evaluate the cost savings attributable to the implementation of a continuous monitoring system in a medical-surgical unit and to determine the return on investment associated with its implementation. Return on investment analysis. A 316-bed community hospital. Medicine, surgery, or trauma patients admitted or transferred to a 33-bed medical-surgical unit. Each bed was equipped with a monitoring unit, with data collected and compared in a 9-month preimplementation period to a 9-month postimplementation period. Two models were constructed: a base case model (A) in which we estimated the total cost savings of intervention effects and a conservative model (B) in which we only included the direct variable cost component for the final day of length of stay and treatment of pressure ulcers. In the 5-year return on investment model, the monitoring system saved between $3,268,000 (conservative model B) and $9,089,000 (base model A), given an 80% prospective reimbursement rate. A net benefit of between $2,687,000 ($658,000 annualized) and $8,508,000 ($2,085,000 annualized) was reported, with the hospital breaking even on the investment after 0.5 and 0.75 of a year, respectively. The average net benefit of implementing the system ranged from $224 per patient (model B) to $710 per patient (model A) per year. A multiway sensitivity analyses was performed using the most and least favorable conditions for all variables. In the case of the most favorable conditions, the analysis yielded a net benefit of $3,823,000 (model B) and $10,599,000 (model A), and for the least favorable conditions, a net benefit of $715,000 (model B) and $3,386,000 (model A). The return on investment for the sensitivity analysis ranged from 127.1% (25.4% annualized) (model B) to 601.7% (120.3% annualized) (model A) for the least favorable conditions and from 627.5% (125.5% annualized) (model B) to 1739.7% (347.9% annualized) (model A) for the most favorable conditions. Implementation of this monitoring system was associated with a highly positive return on investment. The magnitude and timing of these expected gains to the investment costs may justify the accelerated adoption of this system across remaining inpatient non-ICU wards of the community hospital.

7 October 2017 in Health Information Science and Systems
Verified
Journal Article
Open access
PDF file
AKAlan L. Kaplan
Alan L. Kaplan
ECErica R. Cohen
Erica R. Cohen
EZEyal Zimlichman
Eyal Zimlichman
Objective: To understand usage patterns and clinical efficacy of Hello Heart, an mHealth technology application designed to facilitate patient engagement in managing hypertension. Methods: In this single-arm observational study, all subjects with ≥2 blood pressure (BP) recordings were included. The cohort was divided into subgroups by weeks passed since download that patients were still recording measurements. Changes in BP were compared between subgroups. Results: Of 5115 eligible subjects, 3803 (74%) recorded BP for ≥2 weeks. In the 4-week subgroup, 23% achieved BP reduction of ≥10 mmHg versus 24% in the 22-week subgroup (p < 0.001). Among 783 subjects reporting baseline hypertension 57% of the 4-week and 69% of the 22-week subgroups achieved BP normalization (all p < 0.001). Conclusions: We show significant decrease in BP with improved metrics over time. Higher engagement was associated with greater BP reduction and engagement was higher among those with greater clinical need of BP control. Practice implications: Hello Heart represents an operational mHealth technology to improve patient engagement and clinical outcomes.

NPNirit Putievsky Pilosof
Nirit Putievsky Pilosof
MBMichael Barrett
Michael Barrett
EOEivor Oborn
Eivor Oborn
GBGalia Barkai
Galia Barkai
IPItai M. Pessach
Itai M. Pessach
EZEyal Zimlichman
Eyal Zimlichman
The challenges of the COVID-19 pandemic have led to the development of new hospital design strategies and models of care. To enhance staff safety while preserving patient safety and quality of care, hospitals have created a new model of remote inpatient care using telemedicine technologies. The design of the COVID-19 units divided the space into contaminated and clean zones and integrated a control room with audio-visual technologies to remotely supervise, communicate, and support the care being provided in the contaminated zone. The research is based on semi-structured interviews and observations of care processes that implemented a new model of inpatient telemedicine at Sheba Medical Center in Israel in different COVID-19 units, including an intensive care unit (ICU) and internal medicine unit (IMU). The study examines the impact of the diverse design layouts of the different units associated with the implementation of digital technologies for remote care on patient and staff safety. The results demonstrate the challenges and opportunities of integrating inpatient telemedicine for critical and intermediate care to enhance patient and staff safety. We contribute insights into the design of hospital units to support new models of remote care and suggest implications for Evidence-based Design (EBD), which will guide much needed future research.

13 June 2019 in BMC Public Health
Verified
Journal Article
Open access
PDF file
CACarole Elodie Aubert
Carole Elodie Aubert
JSJeffrey L. Schnipper
Jeffrey L. Schnipper
NFNiklaus Fankhauser
Niklaus Fankhauser
Pedro Marques-VidalPedro Marques-Vidal
Pedro Marques-Vidal
JSJerome Stirnemannn
Jerome Stirnemannn
JDJacques Donzé
Jacques Donzé
Multimorbidity is associated with higher healthcare utilization; however, data exploring its association with readmission are scarce. We aimed to investigate which most important patterns of multimorbidity are associated with 30-day readmission. We used a multinational retrospective cohort of 126,828 medical inpatients with multimorbidity defined as ≥2 chronic diseases. The primary and secondary outcomes were 30-day potentially avoidable readmission (PAR) and 30-day all-cause readmission (ACR), respectively. Only chronic diseases were included in the analyses. We presented the OR for readmission according to the number of diseases or body systems involved, and the combinations of diseases categories with the highest OR for readmission. Multimorbidity severity, assessed as number of chronic diseases or body systems involved, was strongly associated with PAR, and to a lesser extend with ACR. The strength of association steadily and linearly increased with each additional disease or body system involved. Patients with four body systems involved or nine diseases already had a more than doubled odds for PAR (OR 2.35, 95%CI 2.15–2.57, and OR 2.25, 95%CI 2.05–2.48, respectively). The combinations of diseases categories that were most strongly associated with PAR and ACR were chronic kidney disease with liver disease or chronic ulcer of skin, and hematological malignancy with esophageal disorders or mood disorders, respectively. Readmission was associated with the number of chronic diseases or body systems involved and with specific combinations of diseases categories. The number of body systems involved may be a particularly interesting measure of the risk for readmission in multimorbid patients.